Connection

Zihai Li to Immunotherapy

Back to Details
This is a "connection" page, showing publications Zihai Li has written about Immunotherapy.
Zihai Li
Connection Strength
1.434
Immunotherapy
  1. Recent updates in cancer immunotherapy: a comprehensive review and perspective of the 2018 China Cancer Immunotherapy Workshop in Beijing. J Hematol Oncol. 2018 12 21; 11(1):142.
    View in: PubMed
    Score: 0.538
  2. Targeting inflammasome/IL-1 pathways for cancer immunotherapy. Sci Rep. 2016 10 27; 6:36107.
    View in: PubMed
    Score: 0.464
  3. Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors. JCI Insight. 2021 09 08; 6(17).
    View in: PubMed
    Score: 0.163
  4. IL-2 and Beyond in Cancer Immunotherapy. J Interferon Cytokine Res. 2018 02; 38(2):45-68.
    View in: PubMed
    Score: 0.127
  5. IL-2Ra mediates temporal regulation of IL-2 signaling and enhances immunotherapy. Sci Transl Med. 2015 Oct 28; 7(311):311ra170.
    View in: PubMed
    Score: 0.108
  6. Fueling Cancer Immunotherapy With Common Gamma Chain Cytokines. Front Immunol. 2019; 10:263.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.